Zhejiang Dongjian Pharmaceutical Co., Ltd
 

Oncology

Name

CAS Number

Application

Stage

Abiraterone

154229-19-3

Prostate cancer

A

Carfilzomib

868540-17-4

Multiple myeloma

A

Ceritinib

1032900-25-6

Non-small cell lung cancer

A

Ibrutinib

936563-96-1

Chronic lymphocytic leukaemia, MALT lymphoma, Mantle-cell lymphoma, Waldenstrom's macroglobulinaemia

A

Idelalisib

870281-82-6

Chronic lymphocytic leukaemia, Follicular lymphoma

B

Nintedanib

656247-18-6

Idiopathic pulmonary fibrosis, Non-small cell lung cancer

B

Olaparib

763113-22-0

Ovarian cancer

A

Osimertinib (AZD9291)

1421373-65-0

Non-small cell lung cancer

A

Palbociclib

571190-30-2

Breast cancer

A

Pralatrexate

146464-95-1

Peripheral T cell lymphoma

A

Ribociclib

1211441-98-3

Breast cancer

C

Tipiracil HCl

183204-72-0

Rectal cancer

A

Venetoclax

1257044-40-8

Chronic lymphocytic leukaemia

C

Diabetes

Name

CAS Number

Application

Stage

Canagliflozin

842133-18-0

Type 2 diabetes mellitus

A

Dapagliflozin

461432-26-8

Type 2 diabetes mellitus

A

Linagliptin

668270-12-0

Type 2 diabetes mellitus

A

Omarigliptin

1226781-44-7

Type 2 diabetes mellitus

A

Sitagliptin

486460-32-6

Type 2 diabetes mellitus

A

Teneligliptin

760937-92-6

Type 2 diabetes mellitus

A

Trelagliptin

865759-25-7

Type 2 diabetes mellitus

B

HCV

Name

CAS Number

Application

Stage

Elbasvir

1370468-36-2

HCV

B

Ledipasvir

1256388-51-8

HCV

A

Sofosbuvir

1190307-88-0

HCV

A

Telaprevir

402957-28-2

HCV

A

Velpatasvir

1377049-84-7

HCV

B

Favipiravir

259793-96-9

Influenza virus infections

B

Cardio Cerebral Vascular

Name

CAS Number

Application

Stage

Anacetrapib

875446-37-0

Hypercholesterolemia

B

Apixaban

503612-47-3

Venous Thromboembolism(VTE)

A

Bosentan Hydrate

157212-55-0

Pulmonary arterial hypertension; Skin ulcer

A

Dronedarone

141626-36-0

Atrial fibrillation, Atrial flutter

A

Macitentan

441798-33-0

Pulmonary arterial hypertension

B

Rivaroxaban

366789-02-8

Venous Thromboembolism(VTE)

A

Selexipag

475086-01-2

Pulmonary arterial hypertension

B

Ticagrelor

274693-27-5

Acute coronary syndromes

A

LCZ696

Valsartan/Sacubitril (1:1)

936623-90-4

Heart Failure

A

Nervous System

Name

CAS Number

Application

Stage

Asenapine

65576-45-6

Bipolar disorders, Schizophrenia

A

Brivaracetam

357336-20-0

Epilepsy

A

Eletriptan

177834-92-3

Menstrual migraine, Migraine

A

Lacosamide

175481-36-4

Partial epilepsies

B

Ramelteon

196597-26-9

Insomnia

A

Rotigotine

125572-93-2

Parkinson's disease, Restless legs syndrome

A

Suvorexant

1030377-33-3

Insomnia

B

Vilazodone

163521-12-8

Major depressive disorder

A

Vortioxetine

960203-27-4

Major depressive disorder

B

Anti-infection

Name

CAS Number

Application

Stage

Avibactam

1192500-31-4

cIAI/cUTI

B

Isavuconazole

241479-67-4

Antifungal

B

Posaconazole

171228-49-2

Antifungal

A

Tedizolid

856866-72-3

Skin and soft tissue infections

C

Voriconazole

137234-62-9

Antifungal

A

Immune System

Name

CAS Number

Application

Stage

Apremilast

608141-41-9

Plaque psoriasis, Psoriatic arthritis

C

Bazedoxifene

198481-33-3

Postmenopausal osteoporosis

B

Odanacatib

603139-19-1

Osteoporosis

A

Tofacitinib

477600-75-2

Rheumatoid arthritis

A

Others

Name

CAS Number

Application

Stage

Bedaquiline

843663-66-1

Tuberculosis

A

Cinacalcet

226256-56-0

Hypercalcaemia; Primary hyperparathyroidism; Secondary hyperparathyroidism

A

Darifenacin

133099-04-4

Overactive bladder

A

Eluxadoline

864821-90-9

Irritable bowel syndrome

A

Fesoterodine

286930-02-7

Overactive bladder

A

Silodosin

160970-64-9

Benign prostatic hyperplasia

A

Trifluridine

70-00-8

Eye infection

A

Varenicline

249296-44-4

Smoking withdrawal

B

Zilpaterol

119520-06-8

Asthma

A

Tildipirosin

328898-40-4

Antibiotic (veterinary drug)

A

Linezolid

165800-03-3

Anti-inflammatory

A

Zopiclone

43200-80-2

Cardiovascular

A

Cefuroxime

55268-75-2

Anti-inflammatory

A

Cefodizime sodium

86329-79-5

Anti-inflammatory

A

Cefoxitin sodium

33564-30-6

Anti-inflammatory

A

Cefminox

75481-73-1

Anti-inflammatory

A

Cefozopran HCl

113981-44-5

Anti-inflammatory

A

Rabeprazole sodium

117976-90-6

Respiratory

A

Fexofenadine

83799-24-0

Respiratory

A

Tamsulosin hydrochloride

106463-17-6

Urinary system

A

Raloxifene

84449-90-1

Cardiovascular

A

Ganciclovir

82410-32-0

Anti-tumor

A

Mycophenolate mofetil

128794-94-5

An immunosuppressant.

A

Propiverine hydrochloride

54556-98-8

urinary incontinence

A

Rocuronium bromide

119302-91-9

competitive neuromuscular blocker

A

Atorvastatin Calcium

134523-03-8

competitive HMG-CoA reductase

A

Rosuvastatin Calcium

147098-20-2

selective, competitive HMG-CoA reductase inhibitor,Antilipemic

A

Vitamin D Drugs

Name

CAS Number

Application

Stage

1α,25-OH Vitamin D2

60133-18-8

Hyperparathyroidism

A

25-OH Vitamin D2

21343-40-8

Hyperparathyroidism, Renal failure

A

Alfacalcidol

41294-56-8

Hyperparathyroidism, Rickets, Osteoporosis

A

Calcifediol

63283-36-3

Hypoparathyroidism, Rickets, Osteoporosis

A

Calcipotriol

112965-21-6

Psoriasis

A

Calcitriol

32222-06-3

Hypoparathyroidism, Chronic renal dialysis, Osteoporosis

A

Doxercalciferol

54573-75-0

Secondary hyperparathyroidism, Metabolic bone disease

A

Eldecalcitol

104121-92-8

Osteoporosis

B

Falecalcitriol

83805-11-2

Hyperparathyroidism, Osteoporosis

B

Maxacalcitol

103909-75-7

Hyperparathyroidism, Psoriasis

A

Paricalcitol

131918-61-1

Secondary hyperparathyroidism

A

Seocalcitol

134404-52-7

Anti tumor, Immune inhibitors

B

Tacalcitol

57333-96-7

Psoriasis, Vitiligo

A

Note: products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and it's liability is at buyer's risk. Products currently covered by valid US patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1)